RecruitingNot ApplicableNCT07579754

BetterInfo on Women's PrEP Choices and Outcomes in Malawi

BetterInfo Tracing Approach to Evaluate HIV PrEP Choices and Use Over Time Among Women in Blantyre, Malawi

Sponsor

Johns Hopkins Bloomberg School of Public Health

Enrollment

384 participants

Start Date

Jul 14, 2026

Study Type

INTERVENTIONAL

Conditions

Oral Pre-exposure Prophylaxis (PrEP)Long-acting Injectable Cabotegravir for PrEP

Summary

The purpose of this study is to understand PrEP user choices, preferences and implementation impact of the roll-out of long-acting injectable PrEP alongside oral PrEP among women in Blantyre, Malawi.

Eligibility

Sex: FEMALEMin Age: 18 YearsMax Age: 110 Years

Plain Language Summary

Simplified for easier understanding

This clinical trial is studying a behavioral approach called Tracing Strategy for people with long-acting injectable cabotegravir for prep and oral pre-exposure prophylaxis (prep). The study is currently recruiting participants at 1 location. People eligible for this study include women aged 18 Years to 110 Years.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

BEHAVIORALTracing Strategy

Participants will receive the SoC per national guidelines and the tracing strategy. The purpose of this intervention is to ascertain the PrEP outcome of clients who have become LTFU (3 months late for a follow-up visit. The strategy includes 1) phone tracing and 2) field tracing with consent.

Locations(1)

Johns Hopkins Research Project Malawi

Blantyre, Malawi

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT07579754

Related Trials

PathToScale: The PERSIST Trial

NCT072217471 location

PathToScale: An Implementation Evaluation

NCT063191051 location